
Court resolves key costs questions in Cadac Pension Fund case
The High Court overturns an earlier disallowance of the curator’s costs and reaffirms that former trustees remain personally liable for curatorship and inspection expenses.
The government finally cuts payers of personal income tax some slack – and increases the medical scheme tax credits.

The High Court overturns an earlier disallowance of the curator’s costs and reaffirms that former trustees remain personally liable for curatorship and inspection expenses.

The legislation will strengthen reporting and governance obligations across the non-profit, corporate, and financial sectors.

Bonitas, Medscheme, and PHA trade accusations as court papers, whistleblower claims, and a CMS probe intensify the battle over medical scheme contracts.

The High Court voids the deregistration of Veritas Capital Africa, allowing HGG’s liquidators to pursue the recovery of R20.49m allegedly transferred before its collapse.

Ministerial Directives issued in July 2021 applied only to specified businesses under the Businesses Act, not to FAIS-regulated FSPs.

The central bank’s consultation paper outlines a structured transition to policy-rate-based lending, with fallback protections for legacy contracts.

Sasfin and Sygnia were the runners-up.

The Supreme Court of Appeal confirms that 181 unchallenged court orders obtained by Sunshine Hospital remain enforceable.

The summons argues the NHI Act limits patient choice, centralises provincial health functions, and lacks sufficient financial and institutional feasibility.

The Pension Funds Adjudicator finds that prolonged administrative delays caused material prejudice to the member.

The FSP was entitled, on the information before it, to conclude that the rep no longer satisfied the fit and proper requirements.

The Labour Appeal Court confirms that termination – even for misconduct – does not extinguish a restraint of trade, unless tainted by fraud or bad faith.

Draft amendments to the SRD Regulations have been published to give effect to the grant’s continuation from April 2026 to March 2027.

The judgment delivers a warning to directors: act as your own lawyer without court approval, and your case may be struck out with costs.

The judgment clarifies that when a taxpayer offers over-collateralised security and SARS cannot explain real risk, suspension should follow.

A signed nomination received during the policyholder’s lifetime satisfied the contractual requirements despite an incorrect policy number.

Transferring client data to a personal, unauthorised account is sufficient to undermine the trust and integrity required of a representative.